FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938263308> ?p ?o ?g. }

• W2938263308 endingPage "122" @default.
• W2938263308 startingPage "115" @default.
• W2938263308 abstract "Objective: Paraoxonase (PON) family genes are closely related to the etiology and prognosis of cerebral infarction. This study explored the association of the promoter methylation of PON family genes (PON1, PON2 and PON3) with the risk of cerebral infarction. Materials and methods: In this study, 152 patients with confirmed cerebral infarction were selected as the case group, and 152 healthy controls were selected as the control group. The quantitative methylation-specific PCR (qMSP) was used to determine the promoter methylation levels of PON1, PON2 and PON3 genes. The methylation level was expressed as a methylation reference percentage (PMR). Results: Our results indicated that PON1 methylation was significantly higher in the case group than in the control group (P = 0.0001). On the contrary, PON3 methylation was significantly lower in the case group than in the control group (P = 0.002). In addition, we found that PON2 gene had a very low level of methylation in both case and control groups (PMR = 0). Subgroup analysis showed that PON1 and PON3 methylation were associated with cerebral infarction only in males (PON1, P = 0.0002; PON3, P = 0.007). Interestingly, the methylation levels of PON1 and PON3 were correlated with each other (case: r = 0.418, P = 0.0001; control: r = 0.3, P = 0.0002). Further multiple regression analysis suggested that elevated methylation levels of PON3 were a protective factor for cerebral infarction [OR (95%CI) = 0.979 (0.96, 0.999), β = -0.021, P = 0.035)], highdensity lipoprotein (HDL) and uric acid (UA) also were protective factors for cerebral infarction [HDL, OR (95% CI) = 0.01 (0.003, 0.033), P < 0.0001); UA, OR (95% CI) = 0.995 (0.991, 0.998), P = 0.003)]. The ROC curve analysis found that the combination of PON3, HDL, and UA had a good predictive power for cerebral infarction (AUC=0.878, 95% CI=0.839-0.918, sensitivity 73.7%, specificity 89.7%, P < 0.0001). Conclusion: PON1 and PON3 promoter methylation levels in peripheral blood were closely related. PON1 and PON3 methylation were associated with the risk of cerebral infarction in men. PON3 promoter methylation combined with HDL and UA could be used as potential biomarkers for the diagnosis of cerebral infarction." @default.
• W2938263308 created "2019-04-25" @default.
• W2938263308 creator A5005597238 @default.
• W2938263308 creator A5021249077 @default.
• W2938263308 creator A5030466570 @default.
• W2938263308 creator A5032396875 @default.
• W2938263308 creator A5039909193 @default.
• W2938263308 creator A5040945443 @default.
• W2938263308 creator A5067930766 @default.
• W2938263308 creator A5073481312 @default.
• W2938263308 date "2019-07-10" @default.
• W2938263308 modified "2023-10-18" @default.
• W2938263308 title "PON1 Hypermethylation and PON3 Hypomethylation are Associated with Risk of Cerebral Infarction" @default.
• W2938263308 cites W1866068290 @default.
• W2938263308 cites W1906243828 @default.
• W2938263308 cites W1963384188 @default.
• W2938263308 cites W1975737069 @default.
• W2938263308 cites W1977236236 @default.
• W2938263308 cites W1988048776 @default.
• W2938263308 cites W1988531474 @default.
• W2938263308 cites W1990958459 @default.
• W2938263308 cites W1995457636 @default.
• W2938263308 cites W1996682849 @default.
• W2938263308 cites W1996878421 @default.
• W2938263308 cites W1997544016 @default.
• W2938263308 cites W2009010693 @default.
• W2938263308 cites W2012494764 @default.
• W2938263308 cites W2013323336 @default.
• W2938263308 cites W2037197890 @default.
• W2938263308 cites W2047806321 @default.
• W2938263308 cites W2054877510 @default.
• W2938263308 cites W2077359776 @default.
• W2938263308 cites W2098082628 @default.
• W2938263308 cites W2099040294 @default.
• W2938263308 cites W2100213646 @default.
• W2938263308 cites W2117651434 @default.
• W2938263308 cites W2117988054 @default.
• W2938263308 cites W2122009495 @default.
• W2938263308 cites W2164561520 @default.
• W2938263308 cites W2204169677 @default.
• W2938263308 cites W2258206540 @default.
• W2938263308 cites W2284495621 @default.
• W2938263308 cites W2297759132 @default.
• W2938263308 cites W2536483438 @default.
• W2938263308 cites W2751977980 @default.
• W2938263308 cites W2772435426 @default.
• W2938263308 cites W2773727922 @default.
• W2938263308 cites W2773833204 @default.
• W2938263308 cites W2790801772 @default.
• W2938263308 cites W2800265223 @default.
• W2938263308 cites W2884762454 @default.
• W2938263308 cites W2890504211 @default.
• W2938263308 cites W2901818429 @default.
• W2938263308 cites W2988162852 @default.
• W2938263308 cites W4318471892 @default.
• W2938263308 doi "https://doi.org/10.2174/1567202616666190412154407" @default.
• W2938263308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30977447" @default.
• W2938263308 hasPublicationYear "2019" @default.
• W2938263308 type Work @default.
• W2938263308 sameAs 2938263308 @default.
• W2938263308 citedByCount "10" @default.
• W2938263308 countsByYear W29382633082020 @default.
• W2938263308 countsByYear W29382633082021 @default.
• W2938263308 countsByYear W29382633082022 @default.
• W2938263308 countsByYear W29382633082023 @default.
• W2938263308 crossrefType "journal-article" @default.
• W2938263308 hasAuthorship W2938263308A5005597238 @default.
• W2938263308 hasAuthorship W2938263308A5021249077 @default.
• W2938263308 hasAuthorship W2938263308A5030466570 @default.
• W2938263308 hasAuthorship W2938263308A5032396875 @default.
• W2938263308 hasAuthorship W2938263308A5039909193 @default.
• W2938263308 hasAuthorship W2938263308A5040945443 @default.
• W2938263308 hasAuthorship W2938263308A5067930766 @default.
• W2938263308 hasAuthorship W2938263308A5073481312 @default.
• W2938263308 hasConcept C101762097 @default.
• W2938263308 hasConcept C104317684 @default.
• W2938263308 hasConcept C126322002 @default.
• W2938263308 hasConcept C134018914 @default.
• W2938263308 hasConcept C135763542 @default.
• W2938263308 hasConcept C146304588 @default.
• W2938263308 hasConcept C150194340 @default.
• W2938263308 hasConcept C190727270 @default.
• W2938263308 hasConcept C2776151105 @default.
• W2938263308 hasConcept C2776509667 @default.
• W2938263308 hasConcept C2779450755 @default.
• W2938263308 hasConcept C33288867 @default.
• W2938263308 hasConcept C37501387 @default.
• W2938263308 hasConcept C541997718 @default.
• W2938263308 hasConcept C54355233 @default.
• W2938263308 hasConcept C71924100 @default.
• W2938263308 hasConcept C86803240 @default.
• W2938263308 hasConceptScore W2938263308C101762097 @default.
• W2938263308 hasConceptScore W2938263308C104317684 @default.
• W2938263308 hasConceptScore W2938263308C126322002 @default.
• W2938263308 hasConceptScore W2938263308C134018914 @default.
• W2938263308 hasConceptScore W2938263308C135763542 @default.
• W2938263308 hasConceptScore W2938263308C146304588 @default.
• W2938263308 hasConceptScore W2938263308C150194340 @default.

• next